LSE - Delayed Quote
GBp
Shield Therapeutics plc (STX.L)
3.0500
-2.4500
(-44.55%)
At close: 5:10:53 PM GMT
Key Executives
Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Karl Anders Lundstrom
|
CEO & Director | 440.49k | -- | 1962 |
|
Dr. Christian Karl Kurt Schweiger M.D., Ph.D.
|
Co-Founder & Non Executive Director | 96.31k | -- | 1966 |
|
Mr. Michael Jensen
|
Chief Financial Officer | -- | -- | -- |
|
Ms. Lucy Kate Huntington-Bailey
|
General Counsel, Chief Compliance Officer & Company Secretary | -- | -- | -- |
|
Mr. David Childs
|
Senior VP of Manufacturing & Strategic Alliances | -- | -- | -- |
|
Ms. Carol Akinola
|
Head of Pharmacovigilance & Medical Information | -- | -- | -- |
|
Mr. Andrew Hurley
|
Chief Commercial Officer | -- | -- | 1969 |
|
Mr. Bryon Kallert
|
Senior Director of Financial Planning & Analysis | -- | -- | -- |
Shield Therapeutics plc
Northern Design Centre
Baltic Business Quarter
Gateshead, NE8 3DF
United Kingdom
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 61
Description
Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru (ferric maltol), a non-salt based oral therapy for patients to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, United Kingdom.
Corporate Governance
Shield Therapeutics plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
